Qteros Secures $22 Million of Financing to Accelerate Cellulosic Ethanol Program

Biotech start-up Qteros (Marlborough, MA) says it has successfully closed a deal to raise $22 million as part of its Series C round of financing. Qteros has developed Consolidated Bioprocessing (CBP), a platform for what it says is the lowest-cost production of cellulosic ethanol. The funds are due to be used to accelerate the company's development and commercialization plans.   “I'm pleased to have completed this first phase of financing for the company which represents broad participation from both existing and new investors," says John A...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers